AU707366B2 - Long-acting oxytetracycline composition - Google Patents

Long-acting oxytetracycline composition Download PDF

Info

Publication number
AU707366B2
AU707366B2 AU28043/95A AU2804395A AU707366B2 AU 707366 B2 AU707366 B2 AU 707366B2 AU 28043/95 A AU28043/95 A AU 28043/95A AU 2804395 A AU2804395 A AU 2804395A AU 707366 B2 AU707366 B2 AU 707366B2
Authority
AU
Australia
Prior art keywords
amount
composition
oxytetracycline
magnesium
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU28043/95A
Other languages
English (en)
Other versions
AU2804395A (en
Inventor
Drew Holmes
Alan Patterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norbrook Laboratories Ltd
Original Assignee
Norbrook Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Laboratories Ltd filed Critical Norbrook Laboratories Ltd
Publication of AU2804395A publication Critical patent/AU2804395A/en
Application granted granted Critical
Publication of AU707366B2 publication Critical patent/AU707366B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU28043/95A 1994-07-09 1995-07-05 Long-acting oxytetracycline composition Expired AU707366B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9413873A GB9413873D0 (en) 1994-07-09 1994-07-09 Long-acting oxytetracycline composition
GB9413873 1994-07-09
PCT/GB1995/001583 WO1996001634A1 (en) 1994-07-09 1995-07-05 Long-acting oxytetracycline composition

Publications (2)

Publication Number Publication Date
AU2804395A AU2804395A (en) 1996-02-09
AU707366B2 true AU707366B2 (en) 1999-07-08

Family

ID=10758078

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28043/95A Expired AU707366B2 (en) 1994-07-09 1995-07-05 Long-acting oxytetracycline composition

Country Status (13)

Country Link
EP (1) EP0769951B1 (de)
JP (2) JP4025925B2 (de)
CN (1) CN1081461C (de)
AT (1) ATE249224T1 (de)
AU (1) AU707366B2 (de)
DE (1) DE69531736T2 (de)
DK (1) DK0769951T3 (de)
ES (1) ES2204958T3 (de)
GB (1) GB9413873D0 (de)
MX (1) MX9700287A (de)
NZ (1) NZ288717A (de)
PT (1) PT769951E (de)
WO (1) WO1996001634A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
TR199902748T2 (xx) * 1997-05-06 2000-05-22 Norbrook Laboratories Limited Uzun s�re etkili antimikrobik maddelerle ilgili geli�meler
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
GB9928343D0 (en) * 1999-11-30 2000-01-26 Vericore Ltd Addition of tetracyclines to animal foodstuffs
US6428975B1 (en) * 2000-01-14 2002-08-06 Blue Ridge Pharmaceuticals, Inc. Methods for determining the presence or absence of microorganisms in lipid-containing compositions
RU2178698C1 (ru) * 2000-11-28 2002-01-27 Закрытое Акционерное Общество "Нита-Фарм" Способ получения композиции магниевого комплекса окситетрациклина пролонгированного действия
NO20014746D0 (no) 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
ES2315123B1 (es) * 2006-09-25 2009-12-30 Divasa-Farmavic, S.A. Composiciones farmaceuticas estables de tetraciclinas en solucion, procedimiento para su obtencion y sus usos.
KR101799304B1 (ko) 2010-05-12 2017-11-20 렘펙스 파머수티클스 인코퍼레이티드 테트라사이클린 조성물
CN103271238B (zh) * 2013-05-10 2014-04-02 中国科学院亚热带农业生态研究所 一种饲料添加剂一乙醇胺的制备方法及应用
CN106309357A (zh) * 2016-11-08 2017-01-11 河南益华动物药业有限公司 兽用盐酸土霉素凝胶植入剂及其制备方法
CN110693826A (zh) * 2019-11-18 2020-01-17 成都新亨药业有限公司 一种兽用长效土霉素注射液及其制备方法
CN111035614B (zh) * 2019-12-20 2024-02-02 北京喜禽药业有限公司 一种高含量土霉素注射液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE747255A (fr) * 1969-03-13 1970-09-14 Diamond Shamrock Corp Compositions injectables d'oxytétracycline
DE2001604C2 (de) * 1970-01-15 1983-04-14 Pfizer Gmbh, 7500 Karlsruhe Verwendung von Polyäthylenglykol zur Herstellung von Oxytetracyclinlösungen zur parenteralen, peroralen und lokalen Anwendung
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
CA1163197A (en) * 1980-04-10 1984-03-06 Herman Horn Injectable oxytetracycline compositions
NL178941C (nl) * 1982-06-15 1986-06-16 Aesculaap Bv Werkwijze voor de bereiding van een waterig oxytetracyclinepreparaat.
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5075295A (en) * 1989-12-12 1991-12-24 Boehringer Ingelheim Animal Health, Inc. Novel oxytetracycline compositions

Also Published As

Publication number Publication date
JP2007326875A (ja) 2007-12-20
CN1156963A (zh) 1997-08-13
CN1081461C (zh) 2002-03-27
EP0769951B1 (de) 2003-09-10
ES2204958T3 (es) 2004-05-01
JPH10502628A (ja) 1998-03-10
WO1996001634A1 (en) 1996-01-25
DK0769951T3 (da) 2004-01-12
NZ288717A (en) 1998-02-26
MX9700287A (es) 1998-10-31
DE69531736D1 (de) 2003-10-16
EP0769951A1 (de) 1997-05-02
AU2804395A (en) 1996-02-09
GB9413873D0 (en) 1994-08-31
PT769951E (pt) 2003-12-31
ATE249224T1 (de) 2003-09-15
DE69531736T2 (de) 2004-07-08
JP4804431B2 (ja) 2011-11-02
JP4025925B2 (ja) 2007-12-26

Similar Documents

Publication Publication Date Title
JP4804431B2 (ja) 長時間作用オキシテトラサイクリン組成物
US4086332A (en) Doxycycline compositions
GB1563478A (en) Tetracycline antibiotic compositions
US5082863A (en) Pharmaceutical composition of florfenicol
KR19990076617A (ko) 주사용 퀴놀론 제제
US6310053B1 (en) Long-acting oxytetracycline composition
US6110905A (en) Long-acting oxytetracycline composition
AU2003281472A1 (en) Levamisole, Avermectins or similar in pyrrolidone solvent
US4081527A (en) Chlortetracycline compositions
US4259331A (en) Oxytetracycline compositions
WO1996001634B1 (en) Long-acting oxytetracycline composition
US4402949A (en) Stable solutions of hydrogenated ergotalkaloids
CA2194576C (en) Long-acting oxytetracycline composition
EP0021847B1 (de) Langwirkende injizierbare Sulfonamid-Zusammensetzungen
FI57883C (fi) Foerfarande foer framstaellning av en stabil klortetracyklinloesning
JPH0112728B2 (de)